Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Board Appointment

24 Sep 2008 07:00

RNS Number : 1282E
Futura Medical PLC
24 September 2008
 



For immediate release 

24 September 2008

Futura Medical plc

("Futura" or "the Group" or "the Company")

Appointment of Finance Director

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that Derek Martin, who joined Futura as Financial Controller in April 2007, has been appointed to the Board of Futura as Finance Director with immediate effect

Derek Adrian Martin, age 47, is a chartered accountant with a breadth of experience gained across a number of sectors, including technology and retail, at private and publicly quoted companies of varying sizes.

Prior to joining Futura, Mr Martin was a financial controller at Thales.  Between 2005 and 2007 he was financial controller at Links of London Limited, the jewellery chain, before its disposal to Folli Follie, and between 2001 and 2005 he was financial controller at Entuity Limited, a US software company. Mr Martin gained AIM experience in the role of financial controller at World Telecom plc, between 1996 and 2001, prior to the company's sale to Torc Telecom Limited.

James Barder, Futura's Chief Executive, said: "I am delighted to welcome Derek to the role of Finance Director and to Futura's Board. He has worked at Futura in the role of Financial Controller since April 2007 and has proved himself to be a highly competent finance executive. I look forward to his contribution to Futura's Board."

There are no further disclosures to be made in accordance with Schedule 2 (g) of the AIM rules.

For any further information please contact:

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 

Canaccord Adams

Ryan Gaffney / Adria Da Breo Richards

Tel: +44 (0) 20 7050 6500 

For media enquiries please contact: 

Buchanan Communications

Mark Court / Rebecca Skye Dietrich

Tel: +44 (0) 20 7466 5000

 

  

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQXLFLVKBBBBF
Date   Source Headline
4th Jun 20267:00 amRNSNotice of AGM & availability of Annual Report
1st Jun 20263:30 pmRNSBlock Listing Six Monthly Return
22nd May 202612:06 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSUnaudited Results for the Year Ended 31 Dec 2025
20th Apr 20267:00 amRNSNotice of Results & Investor Presentation
23rd Mar 20267:00 amRNSPositive Eroxon® & Eroxon® “Intense” HUT results
18th Mar 20267:00 amRNSFormal Grant of US Patent
17th Mar 202611:37 amRNSHolding(s) in Company
20th Feb 20264:06 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSPatent notice of allowance granted for the US
4th Feb 20267:00 amRNSTrading Update
13th Jan 202612:53 pmRNSHolding(s) in Company
13th Jan 202612:51 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSResults of WSD4000 Early Feasibility Study
7th Jan 20264:34 pmRNSNotification of major holdings
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
30th Dec 20255:31 pmRNSNotification of major holdings
30th Dec 20255:31 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
12th Dec 20254:18 pmRNSNotification of major holdings
10th Dec 202512:01 pmRNSNotification of major holdings
10th Dec 202512:00 pmRNSNotification of major holdings
10th Dec 20257:00 amRNSPatent notice of allowance granted for China
9th Dec 20253:59 pmRNSBlock Listing Six Monthly Return
8th Dec 20251:34 pmRNSNotification of major holdings
8th Dec 202512:18 pmRNSDirectors' / PDMR dealing
4th Dec 20253:43 pmRNSNotification of major holdings
4th Dec 20253:41 pmRNSNotification of major holdings
3rd Dec 20257:00 amRNSBoard change
2nd Dec 202511:27 amRNSResult of General Meeting and Total Voting Rights
14th Nov 20254:40 pmRNSPCA Dealing
13th Nov 20254:35 pmRNSPosting of Circular and Notice of GM
13th Nov 20257:00 amRNSFundraise of £2.75 million
3rd Nov 202511:04 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSResults for the six months ended 30 June 2025
26th Sep 202512:11 pmRNSNotice of Results and Investor Presentation
19th Sep 20257:00 amRNSTrading, Business and Strategic Review Update
29th Aug 20257:00 amRNSTotal Voting Rights
8th Aug 20257:00 amRNSBoard Changes, Business Update & Notice of Results
11th Jul 202511:04 amRNSShare price movement
8th Jul 20257:00 amRNSBoard Changes
20th Jun 20257:00 amRNSResult of AGM
2nd Jun 20253:15 pmRNSBlock Listing Six Monthly Return
27th May 20257:00 amRNSNotice of AGM and availability of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.